Iridex (IRIX) Share-based Compensation Growth (3y) (2013 - 2026)
Analysis
Iridex (IRIX) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 8.37% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -22.92% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 19.64% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -28.31% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 0.55% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 4.11% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 7.30% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -0.59% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 3.40% |
| 10 | Iridex | 12.22 Mn | 7.54 Mn | 4.30 Mn | -19.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 4, 2026 | -19.07% |
| Apr 4, 2026 | -23.59% |
| Jan 3, 2026 | -25.54% |
| Sep 27, 2025 | -37.51% |
| Jun 28, 2025 | -9.26% |
| Mar 29, 2025 | -17.84% |
| Dec 28, 2024 | -28.21% |
| Sep 28, 2024 | -43.04% |
| Jun 29, 2024 | 14.38% |
| Mar 30, 2024 | 2.49% |
| Sep 30, 2023 | 15.15% |
| Jul 1, 2023 | -2.83% |
| Apr 1, 2023 | 70.76% |
| Dec 31, 2022 | 19.16% |
| Oct 1, 2022 | 33.63% |
| Jul 2, 2022 | -18.05% |
| Apr 2, 2022 | -14.53% |
| Jan 1, 2022 | 43.83% |
| Oct 2, 2021 | -2.85% |
| Jul 3, 2021 | -12.29% |